NO155289C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.Info
- Publication number
- NO155289C NO155289C NO803592A NO803592A NO155289C NO 155289 C NO155289 C NO 155289C NO 803592 A NO803592 A NO 803592A NO 803592 A NO803592 A NO 803592A NO 155289 C NO155289 C NO 155289C
- Authority
- NO
- Norway
- Prior art keywords
- saturated
- preparation
- acid derivatives
- analogy procedure
- prostanic acid
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 229920006395 saturated elastomer Polymers 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/80—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings
- C07C59/82—Unsaturated compounds containing keto groups containing rings other than six-membered aromatic rings the keto group being part of a ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/16—Radicals substituted by halogen atoms or nitro radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/098,290 US4271314A (en) | 1979-11-28 | 1979-11-28 | 4,5-Unsaturated prostanoic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO803592L NO803592L (no) | 1981-05-29 |
| NO155289B NO155289B (no) | 1986-12-01 |
| NO155289C true NO155289C (no) | 1987-03-11 |
Family
ID=22268646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO803592A NO155289C (no) | 1979-11-28 | 1980-11-27 | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4271314A (it) |
| JP (1) | JPS5699457A (it) |
| AT (1) | AT379144B (it) |
| AU (1) | AU539192B2 (it) |
| BE (1) | BE886370A (it) |
| CA (1) | CA1192903A (it) |
| CH (1) | CH646147A5 (it) |
| DE (1) | DE3044794A1 (it) |
| DK (2) | DK504680A (it) |
| ES (2) | ES497260A0 (it) |
| FI (1) | FI71552C (it) |
| FR (1) | FR2473516A1 (it) |
| GB (1) | GB2065117B (it) |
| GR (1) | GR72283B (it) |
| IE (1) | IE50574B1 (it) |
| IL (1) | IL61575A (it) |
| IT (1) | IT1207155B (it) |
| NL (1) | NL191386C (it) |
| NO (1) | NO155289C (it) |
| NZ (1) | NZ195666A (it) |
| PT (1) | PT72129B (it) |
| SE (1) | SE436873B (it) |
| ZA (1) | ZA807415B (it) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4529811A (en) * | 1981-03-02 | 1985-07-16 | G. D. Searle & Co. | Process for isolating organic compounds and lithium salt complexes useful in said process |
| US4312994A (en) * | 1981-03-25 | 1982-01-26 | G. D. Searle & Co. | α Chain dienic prostanoic acid derivatives |
| US4754059A (en) * | 1984-11-07 | 1988-06-28 | G. D. Searle & Co. | Omega cycloalkyl prostaglandins |
| US4499296A (en) * | 1983-11-14 | 1985-02-12 | G. D. Searle & Co. | Omega cycloalkyl prostaglandins |
| GB8410396D0 (en) * | 1984-04-24 | 1984-05-31 | Glaxo Group Ltd | Carbocyclic compounds |
| US5011958A (en) * | 1987-06-08 | 1991-04-30 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
| US4785124A (en) * | 1987-06-08 | 1988-11-15 | G. D. Searle & Co. | Process for preparing higher order cuprate complexes |
| US4777275A (en) * | 1987-06-09 | 1988-10-11 | G. D. Searle & Co. | Process of preparing higher order cuprate complexes |
| US5191109A (en) * | 1990-02-02 | 1993-03-02 | Sumitomo Chemical Company, Limited | Process for preparing optically active cyclopentenones |
| CA2295595A1 (en) | 1997-07-09 | 1999-01-21 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
| US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
| US6639111B2 (en) | 2000-01-05 | 2003-10-28 | Ono Pharmaceutical Co., Ltd. | 5-thia-ω-(substituted phenyl)-prostaglandin E alcohols, process for preparing the alcohols and pharmaceutical preparations containing the same as the active ingredient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3965143A (en) * | 1974-03-26 | 1976-06-22 | G. D. Searle & Co. | 16-Oxygenated prostanoic acid derivatives |
| US4028419A (en) * | 1976-01-08 | 1977-06-07 | The Upjoin Company | 2-Decarboxy-2-hydroxymethyl-cis-4,5-didehydro-PGE, compounds |
| GB1595118A (en) * | 1977-05-31 | 1981-08-05 | Sumitomo Chemical Co | Prostadienoic acids processes for producing them and compositions containing them |
-
1979
- 1979-11-28 US US06/098,290 patent/US4271314A/en not_active Expired - Lifetime
-
1980
- 1980-11-27 FI FI803685A patent/FI71552C/fi not_active IP Right Cessation
- 1980-11-27 DK DK504680A patent/DK504680A/da not_active Application Discontinuation
- 1980-11-27 NL NL8006473A patent/NL191386C/xx not_active IP Right Cessation
- 1980-11-27 NZ NZ195666A patent/NZ195666A/xx unknown
- 1980-11-27 BE BE0/202950A patent/BE886370A/fr not_active IP Right Cessation
- 1980-11-27 IT IT8050259A patent/IT1207155B/it active
- 1980-11-27 IL IL61575A patent/IL61575A/xx unknown
- 1980-11-27 NO NO803592A patent/NO155289C/no unknown
- 1980-11-27 AU AU64766/80A patent/AU539192B2/en not_active Ceased
- 1980-11-27 IE IE2471/80A patent/IE50574B1/en not_active IP Right Cessation
- 1980-11-27 CA CA000365636A patent/CA1192903A/en not_active Expired
- 1980-11-27 SE SE8008300A patent/SE436873B/sv not_active IP Right Cessation
- 1980-11-27 AT AT0579280A patent/AT379144B/de not_active IP Right Cessation
- 1980-11-27 CH CH879980A patent/CH646147A5/de not_active IP Right Cessation
- 1980-11-27 ZA ZA00807415A patent/ZA807415B/xx unknown
- 1980-11-28 DE DE19803044794 patent/DE3044794A1/de active Granted
- 1980-11-28 ES ES497260A patent/ES497260A0/es active Granted
- 1980-11-28 GR GR63485A patent/GR72283B/el unknown
- 1980-11-28 GB GB8038362A patent/GB2065117B/en not_active Expired
- 1980-11-28 PT PT72129A patent/PT72129B/pt unknown
- 1980-11-28 FR FR8025347A patent/FR2473516A1/fr active Granted
- 1980-11-28 JP JP16791280A patent/JPS5699457A/ja active Granted
-
1981
- 1981-11-30 ES ES507577A patent/ES8300089A1/es not_active Expired
-
1987
- 1987-11-23 DK DK613487A patent/DK162281C/da active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
| NO152215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO162022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater. | |
| NO803851L (no) | Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose | |
| NO156864B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO152935C (no) | Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO153569C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater. | |
| NO156787C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO153496C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater. | |
| NO814424L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser. | |
| NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
| NO162155C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater. | |
| NO155289C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater. | |
| NO152414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO154054C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO160512C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO168478C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater. | |
| NO154795C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater. |